Clinical Trial

Assessment of Bone Density Following Application of BMAC Around Zygomatic Implant

Study acronym: BMAC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective case series is designed to evaluate the effect of autologous bone marrow aspirate concentrate applied around zygomatic implants placed via the intrasinus approach. The study will include adult patients with severe maxillary atrophy requiring zygomatic implant rehabilitation. BMAC will be prepared from iliac crest aspirate and loaded on gelatin sponge at the implant site. Peri-implant bone density will be assessed using CBCT at baseline and 6 months postoperatively. Secondary implant stability will be measured using resonance frequency analysis. (Recruitment has not started yet)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-15.
Trial Details
NCT Number NCT07657026
Lead Sponsor Cairo University
Conditions Severe Maxillary Atrophy
Enrollment 10 participants
Start Date 2026-06-15
Primary Completion 2027-04-15 (estimated)
Study Completion 2027-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-30